These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34080302)

  • 21. Clinical Utility of Short-Term Blood Pressure Measures to Inform Long-Term Blood Pressure Management.
    Wang N; Harris K; Woodward M; Harrap S; Mancia G; Poulter N; Chalmers J; Rodgers A;
    Hypertension; 2023 Mar; 80(3):608-617. PubMed ID: 36468403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.
    Mazza A; Lenti S; Schiavon L; Sacco AP; Dell'Avvocata F; Rigatelli G; Ramazzina E
    Adv Ther; 2017 Apr; 34(4):975-985. PubMed ID: 28299716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
    Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
    J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension.
    Laurent S
    J Hypertens Suppl; 2001 Nov; 19(4):S9-14. PubMed ID: 11848262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights from ADVANCE.
    Chalmers J; Kengne AP; Joshi R; Perkovic V; Patel A
    J Hypertens Suppl; 2007 Jun; 25(1):S23-30. PubMed ID: 17579315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized evaluation of a novel, fixed-dose combination of perindopril 3.5 mg/amlodipine 2.5 mg as a first-step treatment in hypertension.
    Laurent S; Parati G; Chazova I; Sirenko Y; Erglis A; Laucevicius A; Farsang C
    J Hypertens; 2015 Mar; 33(3):653-61; discussion 662. PubMed ID: 25479022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B
    J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
    Naelten G; Liu KL; Chapuis B; Lo M
    Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly.
    Sampalis JS; Psaradellis E; Stutz M; Rickard J; Rampakakis E
    Drugs R D; 2018 Dec; 18(4):283-293. PubMed ID: 30448890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of Perindopril in the reduction of cardiovascular events.
    Campbell DJ
    Vasc Health Risk Manag; 2006; 2(2):117-24. PubMed ID: 17319455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis.
    Glasziou PP; Clarke P; Alexander J; Rajmokan M; Beller E; Woodward M; Chalmers J; Poulter N; Patel A
    Med J Aust; 2010 Sep; 193(6):320-4. PubMed ID: 20854235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension.
    Matheson AJ; Cheer SM; Goa KL
    Drugs; 2001; 61(8):1211-29. PubMed ID: 11465878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation.
    van der Leeuw J; Visseren FL; Woodward M; Zoungas S; Kengne AP; van der Graaf Y; Glasziou P; Hamet P; MacMahon S; Poulter N; Grobbee DE; Chalmers J
    Hypertension; 2015 Jan; 65(1):115-21. PubMed ID: 25312436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular legacy beyond blood pressure control: benefits of perindopril/indapamide combination in hypertensive patients with diabetes.
    Lévy BI; Taddei S
    Curr Med Res Opin; 2018 Sep; 34(9):1557-1570. PubMed ID: 29307229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study.
    Mourad JJ; Lameira D; Guillausseau PJ
    Vasc Health Risk Manag; 2008; 4(2):443-51. PubMed ID: 18561520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of Perindopril/Indapamide Single-Pill Combination in Uncontrolled Patients with Hypertension: A Pooled Analysis of the FORTISSIMO, FORSAGE, ACES and PICASSO Observational Studies.
    Dézsi CA; Glezer M; Karpov Y; Brzozowska-Villatte R; Farsang C
    Adv Ther; 2021 Jan; 38(1):479-494. PubMed ID: 33150570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ADVANCE trial: clarifying the role of perindopril/indapamide fixed-dose combination in the reduction of cardiovascular and renal events in patients with diabetes mellitus.
    Waeber B; de la Sierra A; Ruilope LM
    Am J Cardiovasc Drugs; 2009; 9(5):283-91. PubMed ID: 19791837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood pressure lowering in patients with cerebrovascular disease: results of the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) pilot phase.
    Neal B; Anderson C; Chalmers J; MacMahon S; Rodgers A
    Clin Exp Pharmacol Physiol; 1996 May; 23(5):444-6. PubMed ID: 8713688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the perindopril protection against recurrent stroke study (PROGRESS) trial.
    Arima H; Anderson C; Omae T; Woodward M; Hata J; Murakami Y; Macmahon S; Neal B; Chalmers J;
    Stroke; 2011 Aug; 42(8):2339-41. PubMed ID: 21700945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.